ERSOT
TEVA icon

Employees Retirement System of Texas’s Teva Pharmaceuticals TEVA Stock Holding History

Employees Retirement System of Texas’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,180
Closed -$467K – 335
2024
Q4 		$467K Hold
21,180
– – ﹤0.01% 283
2024
Q3 		$382K Buy
+21,180
New +$371K ﹤0.01% 305
2022
Q3 		– Sell
-41,000
Closed -$308K – 644
2022
Q2 		$308K Hold
41,000
– – ﹤0.01% 684
2022
Q1 		$385K Hold
41,000
– – ﹤0.01% 717
2021
Q4 		$328K Hold
41,000
– – ﹤0.01% 733
2021
Q3 		$399K Hold
41,000
– – ﹤0.01% 757
2021
Q2 		$406K Sell
41,000
-30,000
-42% -$318K ﹤0.01% 720
2021
Q1 		$819K Hold
71,000
– – 0.01% 685
2020
Q4 		$685K Hold
71,000
– – 0.01% 611
2020
Q3 		$640K Hold
71,000
– – 0.01% 665
2020
Q2 		$875K Buy
+71,000
New +$803K 0.01% 656
2019
Q3 		– Sell
-268,406
Closed -$2.48M – 1098
2019
Q2 		$2.48M Sell
268,406
-157,945
-37% -$1.9M 0.04% 487
2019
Q1 		$6.68M Sell
426,351
-41,347
-9% -$729K 0.1% 234
2018
Q4 		$7.21M Hold
467,698
– – 0.11% 202
2018
Q3 		$10.1M Sell
467,698
-34,600
-7% -$803K 0.13% 174
2018
Q2 		$12.2M Buy
502,298
+86,800
+21% +$1.77M 0.16% 135
2018
Q1 		$7.1M Sell
415,498
-25,861
-6% -$505K 0.1% 255
2017
Q4 		$8.36M Buy
441,359
+17,823
+4% +$268K 0.11% 239
2017
Q3 		$7.45M Sell
423,536
-8,183
-2% -$184K 0.1% 255
2017
Q2 		$14.3M Sell
431,719
-22,200
-5% -$687K 0.19% 115
2017
Q1 		$14.6M Sell
453,919
-422,946
-48% -$14.4M 0.2% 105
2016
Q4 		$31.8M Sell
876,865
-172,570
-16% -$6.89M 0.43% 41
2016
Q3 		$48.3M Buy
1,049,435
+24,186
+2% +$1.26M 0.65% 23
2016
Q2 		$51.5M Buy
1,025,249
+109,539
+12% +$5.83M 0.71% 20
2016
Q1 		$49M Sell
915,710
-34,382
-4% -$2.02M 0.68% 22
2015
Q4 		$62.4M Buy
950,092
+76,067
+9% +$4.7M 0.86% 14
2015
Q3 		$49.3M Sell
874,025
-134,777
-13% -$8.74M 0.7% 18
2015
Q2 		$59.6M Sell
1,008,802
-117
-0% -$7.22K 0.78% 12
2015
Q1 		$62.9M Buy
1,008,919
+111,116
+12% +$6.46M 0.81% 12
2014
Q4 		$51.6M Sell
897,803
-30,500
-3% -$1.7M 0.66% 19
2014
Q3 		$49.9M Buy
928,303
+4,927
+0.5% +$261K 0.66% 18
2014
Q2 		$48.4M Buy
923,376
+93,550
+11% +$4.78M 0.62% 20
2014
Q1 		$43.8M Buy
829,826
+83,800
+11% +$3.87M 0.58% 29
2013
Q4 		$29.9M Buy
746,026
+173,973
+30% +$6.85M 0.39% 50
2013
Q3 		$21.6M Sell
572,053
-24,900
-4% -$971K 0.27% 71
2013
Q2 		$23.4M Buy
+596,953
New +$23.2M 0.28% 57

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Employees Retirement System of Texas's TEVA Position: Q1 2025 in Review

Employees Retirement System of Texas sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 21,180 shares — an estimated $467K sold.

Employees Retirement System of Texas first reported a position in TEVA in Q2 2013 and held it in 36 quarters. The position peaked at $62.9M in Q1 2015. 561 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Employees Retirement System of Texas reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 21,180 Teva Pharmaceuticals shares in Q1 2025, an estimated $467K.
  • Employees Retirement System of Texas first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 36 quarters.
  • Employees Retirement System of Texas's Teva Pharmaceuticals position peaked at $62.9M in Q1 2015.
  • 561 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Employees Retirement System of Texas's 13F filing for Q1 2025, filed 13 May 2025.